Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023


Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2023 after the close of trading on Tuesday, May 2, 2023. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET.

A live and archived webcast of the event will be available on the "Investors" section of the Pulmonx website at https://investors.pulmonx.com/.

About Pulmonx Corporation

Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for severe lung disease. Pulmonx's Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a "breakthrough device." The Zephyr Valve is commercially available in more than 25 countries, with over 100,000 valves used to treat more than 25,000 patients. For more information on the Zephyr Valves, please visit https://uspatients.pulmonx.com/. For more information on the company, please visit www.Pulmonx.com.

Pulmonx®, Chartis®, StratX®, and Zephyr® are registered trademarks of Pulmonx Corporation.


These press releases may also interest you

at 14:19
Jennifer Mersereau, Senior Partner, Co-Founder & COO, Hamilton ETFs, Patrick Sommerville, Senior Partner, Head of Business Development, Hamilton ETFs, and their team joined Keith Wu, Head, Exchange Traded Products, Toronto Stock Exchange , to open...

at 14:03
New research insights from Info-Tech Tech Research Group will equip food and beverage manufacturers with essential strategies for embracing digital transformation. The global research and advisory firm explains that the industry can significantly...

at 13:50
Canadian General Investments, Limited (CGI)  (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at June 30, 2024 was $62.50, resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 13.3% and...

at 13:40
New research led by the Faculty of Health Sciences at Ontario Tech University and published in Diabetic Medicine, reveals participation in Special Olympics programming is associated with a significantly lower risk of diabetes among adults with...

at 13:30
The July 15 deadline approaches to be eligible for the Canada Carbon Rebate for Small Businesses. This refundable tax credit announced in Budget 2024 returns a portion of federal fuel charge proceeds directly to an estimated 600,000 small and medium...

at 13:22
ÉRIC & DANIEL TADROS, the visionaries behind the Liberty City real estate development, have received support from Tim Draper, a venture capitalist who initially funded Elon Musk for Tesla and SpaceX, and also supported over 20 companies that now...



News published on and distributed by: